2016
DOI: 10.1186/s13613-016-0111-2
|View full text |Cite
|
Sign up to set email alerts
|

Experts’ recommendations for the management of cardiogenic shock in children

Abstract: Cardiogenic shock which corresponds to an acute state of circulatory failure due to impairment of myocardial contractility is a very rare disease in children, even more than in adults. To date, no international recommendations regarding its management in critically ill children are available. An experts’ recommendations in adult population have recently been made (Levy et al. Ann Intensive Care 5(1):52, 2015; Levy et al. Ann Intensive Care 5(1):26, 2015). We present herein recommendations for the management of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
6

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 126 publications
(115 reference statements)
0
15
0
6
Order By: Relevance
“…Despite advances in management techniques and medical therapy, refractory cardiogenic shock remains a lifethreatening condition with high mortality rates (1). Both low cardiac output and poor tissue perfusion characterize cardiogenic shock and hence a great deal of emphasis is placed on the use of inotropic and vasopressor agents, mechanical assistance and fluid maintenance to support cardiac function (2). Mechanical support for the management of cardiogenic shock was first assessed in animal trials as early as the 1930s, with extension to human trials in the late 1960s in the setting of infants with respiratory sepsis (3)(4)(5).…”
Section: Introductionmentioning
confidence: 99%
“…Despite advances in management techniques and medical therapy, refractory cardiogenic shock remains a lifethreatening condition with high mortality rates (1). Both low cardiac output and poor tissue perfusion characterize cardiogenic shock and hence a great deal of emphasis is placed on the use of inotropic and vasopressor agents, mechanical assistance and fluid maintenance to support cardiac function (2). Mechanical support for the management of cardiogenic shock was first assessed in animal trials as early as the 1930s, with extension to human trials in the late 1960s in the setting of infants with respiratory sepsis (3)(4)(5).…”
Section: Introductionmentioning
confidence: 99%
“…Nach der Bestätigung der Diagnose besteht das allgemeine Vorgehen darin, eine Volumenüberladung zu vermeiden. Allerdings können Patienten mit nachgewiesener verminderter Vorlast, die aufgrund klinischer oder biochemischer Gründe oder echokardiographisch angenommen wird, beispielsweise im Rahmen einer geringen Flüssigkeitsaufnahme oder einer damit verbundenen Sepsis von einer vorsichtigen Flüssigkeitstherapie profitieren [ 39 ].…”
Section: Evidenzen Für Die Leitlinienunclassified
“…▶ Tab. 1 Klinische Zeichen akuter Herzinsuffizienz bei Kindern (modifiziert nach [5] Bei Erwachsenen sind Messungen von BNP bzw. NTpro-BNP als Biomarker fest etabliert und verfügen neben dem differenzialdiagnostischen Nutzen über einen prognostischen Wert [10].…”
Section: Cme-fortbildungunclassified
“…Auch im Kindesalter kann die Bestimmung von BNP bzw. NT-pro-BNP zur Diagnosestellung beitragen und wird daher empfohlen [5]. Sie sollte möglich frühzeitig erfolgen und Bestandteil der Laborwertbestimmung sein, wenn die Differenzialdiagnosen akute Herzinsuffizienz oder kardiogener Schock im Raum erwogen werden.…”
Section: Cme-fortbildungunclassified